Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“The Colorectal Cancer Alliance knows that without research, there is no progress, which is why we continue to push boundaries with our Project Cure CRC initiative.
We’re proud to share that Project Cure CRC researchers are publishing articles about their work. In addition, Project Cure CRC recently awarded three new grants to scientists at leading institutions, including Miguel Reina-Campos, La Jolla Institute for Immunology, DaeYong Lee, Virginia Tech Tech, and Kelvin Pond, University of Arizona.
These projects are not only expanding our understanding of colorectal cancer biology but also pushing the boundaries of what’s possible in immunotherapy and precision medicine.
In just two years, Project Cure CRC has:
- Reviewed more than 500 proposals from the world’s top scientists
- Invested nearly $13 million in 32 cutting-edge studies
- Supported discoveries already published in leading scientific journals
These are not just numbers, they represent hope for millions of families.
Colorectal cancer is the second leading cause of cancer death and incidence is growing in younger adults. The urgency has never been greater. Through Project Cure CRC, we’re uniting researchers, patients, and partners to fast-track discoveries and save lives.
Join us in fueling this mission. Whether through partnership, philanthropy, or advocacy, together we can end colorectal cancer in our lifetime.
Read the full press release.
Learn more about Project Cure CRC and how to get involved.”
More posts featuring Colorectal Cancer Alliance.